Ws Management Lllp Adaptimmune Therapeutics PLC Transaction History

Ws Management Lllp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$4.9 - $6.83 $29,110 - $40,577	-5,941 Reduced 4.89%	115,602 $614,000
Q2 2020 Aug 13, 2020	SELL	$2.58 - $12.1 $53,743 - $252,055	-20,831 Reduced 14.63%	121,543 $1.22 Million
Q1 2020 May 13, 2020	SELL	$1.2 - $4.52 $8,559 - $32,241	-7,133 Reduced 4.77%	142,374 $387,000
Q3 2019 Nov 13, 2019	SELL	$1.43 - $3.81 $23,509 - $62,636	-16,440 Reduced 9.91%	149,507 $226,000
Q2 2019 Aug 13, 2019	SELL	$3.23 - $5.41 $63,275 - $105,981	-19,590 Reduced 10.56%	165,947 $667,000
Q1 2019 May 13, 2019	SELL	$3.63 - $6.06 $90,466 - $151,027	-24,922 Reduced 11.84%	185,537 $798,000
Q4 2018 Feb 12, 2019	SELL	$3.76 - $14.16 $324,578 - $1.22 Million	-86,324 Reduced 29.09%	210,459 $1.21 Million
Q2 2018 Aug 13, 2018	BUY	$10.42 - $13.74 $3.09 Million - $4.08 Million	296,783 New	296,783 $3.52 Million

123M

34.2K

16.3K

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $40.8M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

Get notified when there are updates to the investment portfolio of Ws Management Lllp, based on Form 13F filings with the SEC.

Stay updated on Ws Management Lllp with notifications on news.